Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
PBM
PBM News & Events
-
Add to Watchlist
Trade PBM
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
PBM News
Teradyne Q4 Earnings Beat Estimates, Shares Surge
5 days ago
Benzinga
Psyence Biomedical Delays Reverse Stock Split Implementation
6 days ago
stocktwits
Psyence BioMed Announces Share Consolidation Plan
Jan 28 2026
Newsfilter
Psyence Biomedical (PBM) Announces 1-for-6.25 Reverse Stock Split Effective January 20, 2026
Jan 15 2026
seekingalpha
Psyence BioMed Executes 1-for-6.25 Share Consolidation, Reducing Outstanding Shares to 1.02 Million
Jan 15 2026
Globenewswire
Psyence Biomedical Approves 2026 Financial Strategy and Share Repurchase Program
Jan 12 2026
Newsfilter
Psyence BioMed Becomes First Nasdaq Company to Produce GMP-Compliant Ibogaine HCl
Jan 05 2026
Globenewswire
Psyence BioMed Achieves First GMP-Compliant High-Purity Ibogaine Production on Nasdaq
Jan 05 2026
Newsfilter
Show More News
PBM Events
No data
PBM Monitor News
Psyence Biomedical Delays Reverse Stock Split Implementation
Feb 03 2026
Psyence Biomedical Announces Share Consolidation Plan
Feb 02 2026
Psyence Biomedical Ltd. stock rises after crossing above SMA
Jan 28 2026
Psyence Biomedical achieves GMP-compliant ibogaine production
Jan 07 2026
Psyence Biomedical achieves GMP-compliant ibogaine production
Jan 05 2026
Psyence Biomedical Ltd rises amid sector rotation
Dec 26 2025
Psyence Biomedical receives approval for NPX5 in Phase IIb trial
Dec 22 2025
Psyence Biomedical Ltd surges on market strength
Dec 19 2025
Show More Monitor News
PBM Earnings Analysis
No Data
People Also Watch
